Breast Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
Cohort 1 – Monitoring During Chemotherapy Before Surgery:
- People who are willing and able to give written consent before the study begins
- People who are willing and able to follow the safety procedures during the scanning sessions
- Men and women aged between 20 and 80 years old (inclusive) at the time of signing the consent form
- People who are currently receiving chemotherapy before surgery (neoadjuvant chemotherapy) for locally advanced breast cancer
- People who have a biopsy-confirmed diagnosis of locally advanced breast cancer, of any hormone receptor or HER2 type
Cohort 2 – Investigating a Breast Lump:
- People who are willing and able to give written consent before the study begins
- People who are willing and able to follow the safety procedures during the scanning sessions
- Men and women aged between 20 and 80 years old (inclusive) at the time of signing the consent form
- People who have been referred to a breast diagnostic clinic to have a breast lump investigated
Who may not be able to join:
- People who have a history of breast abnormalities, significant breast injury, or breast surgery (such as silicone or saline implants), unrelated to the current breast concern being studied
- People who have any skin abnormalities on either breast, including tattoos, open sores, or broken skin
- People with a current or past history of connective tissue disease (a group of conditions affecting the body's connective tissues — confirm with trial site)
- People who are pregnant or currently breastfeeding
- People who have an implanted electronic device, such as a heart pacemaker, defibrillator, or neurological stimulator
- People with a history of significant anxiety related to undergoing medical tests or diagnostic evaluations
- People with a history of musculoskeletal disease (conditions affecting muscles, bones, or joints) that may cause discomfort during the scanning sessions
- People with a known sensitivity to low-power infrared light, for example due to a skin condition
- People whom the trial investigator or coordinator considers unsuitable for inclusion for any other reason
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Gregory J Czarnota, PhD, MD, Sunnybrook Health Sciences Centre
Phone: (416) 480-6128
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Treatment response correlation between photoacoustic parameters and histopathological measurement.
Can't join this trial?
Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.